These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 27151934

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The effect of complement factor H Y402H polymorphism on the outcome of photodynamic therapy in age-related macular degeneration.
    Seitsonen SP, Jarvela IE, Meri S, Tommila PV, Ranta PH, Immonen IJ.
    Eur J Ophthalmol; 2007; 17(6):943-9. PubMed ID: 18050121
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis.
    Pham B, Thomas SM, Lillie E, Lee T, Hamid J, Richter T, Janoudi G, Agarwal A, Sharpe JP, Scott A, Warren R, Brahmbhatt R, Macdonald E, Straus SE, Tricco AC.
    BMJ Open; 2019 May 28; 9(5):e022031. PubMed ID: 31142516
    [Abstract] [Full Text] [Related]

  • 29. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment.
    Goverdhan SV, Hannan S, Newsom RB, Luff AJ, Griffiths H, Lotery AJ.
    Eye (Lond); 2008 Jun 28; 22(6):849-54. PubMed ID: 17464302
    [Abstract] [Full Text] [Related]

  • 30. Association of Combined Complement Factor H Y402H and ARMS/LOC387715 A69S Polymorphisms with Age-related Macular Degeneration: A Meta-analysis.
    Jabbarpoor Bonyadi MH, Yaseri M, Bonyadi M, Soheilian M, Karimi S.
    Curr Eye Res; 2016 Dec 28; 41(12):1519-1525. PubMed ID: 27269047
    [Abstract] [Full Text] [Related]

  • 31. Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis.
    Jabbarpoor Bonyadi MH, Yaseri M, Bonyadi M, Soheilian M.
    Int Ophthalmol; 2017 Dec 28; 37(6):1397-1409. PubMed ID: 28005184
    [Abstract] [Full Text] [Related]

  • 32. Pharmacogenetics of the treatment response of age-related macular degeneration with ranibizumab and bevacizumab.
    Kanoff J, Miller J.
    Semin Ophthalmol; 2013 Dec 28; 28(5-6):355-60. PubMed ID: 24010796
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of CC-cytokine ligand 2 and complementary factor H Y402H polymorphisms and their interactional association with age-related macular degeneration.
    Bonyadi M, Foruzandeh Z, Mohammadian T, Fotouhi N, Soheilian M, Jabbarpoor Bonyadi MH, Javadzadeh A, Moein H, Yaseri M.
    Acta Ophthalmol; 2016 Dec 28; 94(8):e779-e785. PubMed ID: 27316788
    [Abstract] [Full Text] [Related]

  • 34. Comparison of ARMS2/LOC387715 A69S and CFH Y402H risk effect in wet-type age-related macular degeneration: a meta-analysis.
    Jabbarpoor Bonyadi MH, Yaseri M, Nikkhah H, Bonyadi M, Nazari R, Soheilian M.
    Int Ophthalmol; 2019 Apr 28; 39(4):949-956. PubMed ID: 29423786
    [Abstract] [Full Text] [Related]

  • 35. Age-related macular degeneration and association of CFH Y402H and LOC387715 A69S polymorphisms in a Turkish population.
    Soysal Y, Inan UÜ, Küsbeci T, Imirzalioğlu N.
    DNA Cell Biol; 2012 Mar 28; 31(3):323-30. PubMed ID: 21790300
    [Abstract] [Full Text] [Related]

  • 36. Age-related macular degeneration and modification of systemic complement factor H production through liver transplantation.
    Khandhadia S, Hakobyan S, Heng LZ, Gibson J, Adams DH, Alexander GJ, Gibson JM, Martin KR, Menon G, Nash K, Sivaprasad S, Ennis S, Cree AJ, Morgan BP, Lotery AJ.
    Ophthalmology; 2013 Aug 28; 120(8):1612-8. PubMed ID: 23562165
    [Abstract] [Full Text] [Related]

  • 37. Combined effects of genetic and non-genetic risk factors affect response to ranibizumab in exudative age-related macular degeneration.
    Piermarocchi S, Miotto S, Colavito D, Leon A, Segato T.
    Acta Ophthalmol; 2015 Sep 28; 93(6):e451-7. PubMed ID: 25402348
    [Abstract] [Full Text] [Related]

  • 38. Association between CFH Y402H polymorphism and age related macular degeneration in North Indian cohort.
    Sharma NK, Gupta A, Prabhakar S, Singh R, Sharma SK, Chen W, Anand A.
    PLoS One; 2013 Sep 28; 8(7):e70193. PubMed ID: 23922956
    [Abstract] [Full Text] [Related]

  • 39. Association of Two Polymorphisms, rs1061170 and rs1410996, in Complement Factor H with Age-Related Macular Degeneration in an Asian Population: A Meta-Analysis.
    Wu M, Guo Y, Ma Y, Zheng Z, Wang Q, Zhou X.
    Ophthalmic Res; 2016 Sep 28; 55(3):135-44. PubMed ID: 26727378
    [Abstract] [Full Text] [Related]

  • 40. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration.
    Smailhodzic D, Muether PS, Chen J, Kwestro A, Zhang AY, Omar A, Van de Ven JP, Keunen JE, Kirchhof B, Hoyng CB, Klevering BJ, Koenekoop RK, Fauser S, den Hollander AI.
    Ophthalmology; 2012 Nov 28; 119(11):2304-11. PubMed ID: 22840423
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.